Search Results
Jun 01, 2026, 08:40 ET EngineAI lance le site de production intelligente de Shenzhen et le premier lot de robots humanoïdes T800 sort de la chaîne de production en vue de démarrer une livraison en masse
la production à grande échelle ».Quatre piliers stratégiques pour une qualité inébranlableEn s'appuyant sur ses capacités de R&D indépendantes, EngineAI a mis en place un cadre d'assurance qualité rigoureux reposant sur quatre piliers stratégiques :Contrôle
More news about: EngineAI
Jun 01, 2026, 08:39 ET Labor & Employment Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Suit Against Intuitive Surgical Operations, Inc., for Alleged Failure to Pay Accurate Wages
meal and rest periods, (d) failed to provide accurate itemized wage statements, (e) failed to reimburse for required expenses, (f) failed to pay sick wages, and (g) failed to provide
More news about: Blumenthal Nordrehaug Bhowmik De Blouw LLP
Jun 01, 2026, 08:38 ET Cove Capital Investments Acquires Industrial Distribution Facility in a 100% Debt-Free Transaction for Its New Cove Essential Net Lease Industrial 116 DST Offering
of a mission-critical distribution facility to finalize its new Cove Essential Net Lease Industrial 116 DST offering. The acquisition is a Regulation D, Rule 506(c) offering that is targeting a $14,554,008 equity raise.
More news about: Cove Capital Investments
Jun 01, 2026, 08:30 ET EIT Pharma Highlights New Lonafarnib Analyses at EASL Congress 2026
chronic hepatitis D: extended analyses from the phase 3 D-LIVR trial; presented during the "Viral Hepatitis B and D: New therapies, unapproved therapies or strategies" session on Wednesday, May 27, from 8:30 a.m. to 5:00 p.m. CEST."People living with chronic hepatitis D face a serious and
More news about: EIT Pharma
Jun 01, 2026, 08:30 ET Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
Cardiovascular PipelineSeparately, the Company reaffirmed that it plans to report 12-week data from Part D of the CIRRUS-HCM Phase 2 trial of EDG-7500 in the second quarter of 2026. The 12-week Part D data, which will include safety, echocardiographic, biomarker, and patient-reported outcome assessments
More news about: Edgewise Therapeutics
Jun 01, 2026, 08:04 ET HousMthr Targets the Hidden Labor Behind Travel: The Unpaid Project Manager
Center of Hospitality, & Good Housekeeping. (2025). 2025 U.S. family travel survey. Family Travel Association. indd.adobe.com/view/publication/1db5d9e0-22e3-4f05-a49a-15eb0dd08498/zumk/publication-web-resources/pdf/FTA-Survey2025-Report.pdfNewsweek. (2024, November 11). Man backed for not
More news about: HousMthr
Jun 01, 2026, 08:03 ET Nearmap Expands Roof & Exterior Measurements as P&C Insurers Accelerate Claims Modernization
proprietary aerial imagery with 3D-enabled measurement technology to deliver fast, accurate, and defensible property intelligence directly within Verisk XactAnalysis® and Xactimate®, or through API integration. Measurement reports in PDF format include precise measurements, 3D property models, sketch diagrams,
More news about: Nearmap
Jun 01, 2026, 08:00 ET SystImmune Reports Phase 1 Data for BL-M14D1 Demonstrating Promising Activity in Small-Cell Lung Cancer at ASCO
presentation of Phase 1 data for BL-M14D1 in patients with small-cell lung cancer (SCLC), neuroendocrine carcinoma (NEC), and other solid tumors (BL-M14D1-101, NCT06505824) at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting in Chicago. BL-M14D1 is a DLL3 targeting antibody drug conjugate
More news about: SystImmune, Inc.
Jun 01, 2026, 08:00 ET 技嘉於 COMPUTEX 2026 發表 40 週年限定 X870E 與 X870 AORUS INFINITY 系列主機板
INFINITY 系列核心技術為技嘉獨家 AI 強化超頻技術 X3D Turbo 2.0 模式。內建硬體晶片，可即時監控系統運作狀態與工作負載行為；並搭配大數據訓練的 AI 動態超頻模型，針對每顆處理器進行優化調校，帶來更智慧、快速且最佳化的效能設定，滿足遊戲、創作與高負載運算需求。結合航太科技與資料中心級工程設計的 X870E AORUS INFINITY NEXT，採用火箭推進器等級散熱材料，並將創新的 AI Gyroid M.2 散熱結構透過 3D 金屬列印實現，最高可提升 44% 的散熱表面積。搭配 3D 列印均熱板與蜂巢式金屬背板，技嘉將旗艦級主機板的散熱設計推向突破傳統限制的新層次。此外，該主機板搭載
More news about: GIGABYTE
Jun 01, 2026, 08:00 ET 기가바이트, 컴퓨텍스 2026에서 40주년 기념 X870E 및 X870 AORUS INFINITY 시리즈 메인보드 공개
세계적인 컴퓨터 브랜드 기가바이트(GIGABYTE)가 컴퓨텍스 2026(COMPUTEX 2026)에서 40주년 기념 X870E 및 X870 AORUS INFINITY 시리즈 메인보드를 공개했다. 최신 AMD Ryzen™ 9950X3D2 프로세서용으로 설계된 이 시리즈는 AI 최적화로 최고의 성능을 이끌어내는 X3D Turbo Mode 2.0을 탑재하고 최대 11400 MT/s의 메모리 속도를 지원한다. 제품군에는 열 설계와 전력 공급의 새로운 시대를 이끌 X870E AORUS INFINITY NEXT와 초저지연 메모리 성능을 구현하도록 설계된
More news about: GIGABYTE
Jun 01, 2026, 08:00 ET GIGABYTE Debuts 40th Anniversary X870E and X870 AORUS INFINITY Series Motherboards at COMPUTEX 2026
through rocket thruster-grade thermal materials and advanced 3D metal printing technology. The innovative AI Gyroid M.2 heatsink structure, only achievable through 3D metal printing, delivers up to 44% greater cooling surface area. Combined with a 3D-printed vapor chamber and honeycomb-structured metal backplate,
More news about: GIGABYTE
Jun 01, 2026, 08:00 ET GIGABYTE Debuts 40th Anniversary X870E and X870 AORUS INFINITY Series Motherboards at COMPUTEX 2026
through rocket thruster-grade thermal materials and advanced 3D metal printing technology. The innovative AI Gyroid M.2 heatsink structure, only achievable through 3D metal printing, delivers up to 44% greater cooling surface area. Combined with a 3D-printed vapor chamber and honeycomb-structured metal backplate,
More news about: GIGABYTE
Jun 01, 2026, 08:00 ET GIGABYTE présente l'édition « 40e anniversaire » de ses cartes mères AORUS INFINITY X870E et X870 au salon COMPUTEX 2026
avancée d'impression métallique en 3D. La structure innovante du dissipateur thermique IA gyroïde M.2, obtenue par la technologie exclusive d'impression métallique en 3D, offre une surface de refroidissement jusqu'à 44 % supérieure. Associée à une chambre à vapeur imprimée en 3D et à une plaque arrière métallique
More news about: GIGABYTE
Jun 01, 2026, 08:00 ET GIGABYTE presenta las placas base X870E y X870 AORUS INFINITY Series por su aniversario número 40 en COMPUTEX 2026
cohetes y tecnología avanzada de impresión 3D en metal. La innovadora estructura del disipador AI Gyroid M.2, solo posible mediante impresión 3D en metal, ofrece hasta un 44 % más de superficie de refrigeración. Combinado con una cámara de vapor impresa en 3D y una placa trasera de metal con estructura
More news about: GIGABYTE
Jun 01, 2026, 08:00 ET GIGABYTE lança as placas-mãe X870E e X870 AORUS INFINITY Series de 40º aniversário na COMPUTEX 2026
foguete e tecnologia avançada de impressão 3D em metal. A inovadora estrutura de dissipador de calor AI Gyroid M.2, possível apenas por meio de impressão 3D em metal, oferece até 44% mais área de dissipação térmica o. Combinado com uma câmara de vapor impressa em 3D e uma placa traseira metálica em formato
More news about: GIGABYTE
Jun 01, 2026, 08:00 ET GIGABYTE presenta en COMPUTEX 2026 las motherboards X870E y X870 de la serie AORUS INFINITY por el aniversario 40 de la marca
avanzada de impresión de metal en 3D. La innovadora estructura del disipador de calor Gyroid M.2 con IA, que se obtiene únicamente mediante impresión de metal 3D, proporciona hasta 44 % más de superficie de enfriamiento. En combinación con una cámara de vapor impresa en 3D y una placa posterior metálica
More news about: GIGABYTE
Jun 01, 2026, 08:00 ET GIGABYTE stellt auf der COMPUTEX 2026 die X870E und X870 Motherboards der AORUS INFINITY-Serie zum 40-jährigen Jubiläum vor
Motherboards der Serien X870E und X870 AORUS INFINITY zum 40-jährigen Jubiläum vor. Die für den AMD Ryzen™ 9 9950X3D2 Dual Edition Prozessor entwickelte Serie verfügt über den KI-gestützten X3D Turbo Mode 2.0 und unterstützt Speichergeschwindigkeiten von bis zu 11.400 MT/s. Die Produktreihe umfasst das X870E
More news about: GIGABYTE
Jun 01, 2026, 08:00 ET GIGABYTE、COMPUTEX 2026において40周年記念のX870EおよびX870 AORUS INFINITYシリーズマザーボードを発表
台北、2026年6月1日 /PRNewswire/ -- 世界をリードするコンピューターブランドであるGIGABYTEは、COMPUTEX 2026において、40周年記念のX870EおよびX870 AORUS INFINITYシリーズマザーボードを発表しました。最新のAMD Ryzen™ 9950X3D2プロセッサー向けに構築されたこのシリーズは、ピーク性能を実現するためのAI強化型X3D Turbo Mode 2.0を搭載し、最大11,400 MT/sのメモリ速度をサポートします。ラインナップには、熱設計と電力供給を新時代へと押し上げるよう設計されたX870E AORUS INFINITY NEXTと、超低レイテンシのメモリ性能を実現するよう設計されたX870
More news about: GIGABYTE
Jun 01, 2026, 08:00 ET GIGABYTE ra mắt dòng bo mạch chủ AORUS INFINITY X870E và X870 nhân kỷ niệm 40 năm tại COMPUTEX 2026
cấp hàng không vũ trụ cùng công nghệ in kim loại 3D tiên tiến. Cấu trúc tản nhiệt AI Gyroid M.2 đầy tính đổi mới, chỉ có thể chế tạo thông qua công nghệ in kim loại 3D, giúp tăng diện tích bề mặt làm mát lên đến 44%. Khi kết hợp cùng buồng hơi in 3D và tấm ốp lưng kim loại cấu trúc tổ ong, giải pháp
More news about: GIGABYTE
Jun 01, 2026, 08:00 ET Lynk Pharmaceuticals Announces NMPA Approval of LNK01004 Ointment's Phase II Clinical Trial for the Treatment of Vitiligo and Chronic Hand Eczema
innovation, developing differentiated small-molecule therapies, and providing superior oral alternatives to biologics. The company was founded by senior R&D leaders from Pfizer, MSD, and Johnson & Johnson, focusing on the JAK-STAT and expanding to TYK2 signaling pathways, and mastering targeted protein
More news about: Lynk Pharmaceuticals Co., Ltd.
Jun 01, 2026, 08:00 ET MISUMI Americas Unveils AI-Powered Supply Chain Platform to Redefine Mechanical Sourcing
engineering support to help customers improve manufacturability, reduce production risk, and accelerate readiness for production. Services include 3D CAD modeling, 2D drawing creation, redesign and optimization of existing parts and assemblies for specific manufacturing processes, Design for Manufacturability
More news about: MISUMI Americas
Jun 01, 2026, 08:00 ET Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development
"Actinium is developing what I believe is one of the most compelling radiotherapy pipelines today." said Dr. Heeger. "Their biology-driven R&D has yielded several highly differentiated, even unique, assets that offer real opportunity to bring transformative therapies to patients with limited
More news about: Actinium Pharmaceuticals, Inc.
Jun 01, 2026, 08:00 ET Wockhardt Receives U.S. FDA Approval for ZAYNICH™ (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis
https://www.cdc.gov/antimicrobial-resistance/about/index.html3 Marantidis, J., & Sussman, R. D. (2023). Unmet needs in complicated urinary tract infections: Challenges, recommendations, and emerging treatment pathways. Infection and Drug Resistance,
More news about: Wockhardt
Jun 01, 2026, 07:43 ET New Memoir Chronicles a Legally Blind Student's Journey Through College, Friendship and Faith
unapologetic nerdiness to every anecdote he retells. When he's not writing, Josh might could be found watching obscure anime, reading his KJV Bible, running D&D campaigns, or constructing puns over sniffers of brandy. To learn more, please visit
More news about: Archway Publishing
Jun 01, 2026, 07:00 ET Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic
preparation for Decoy's lead D-MAV candidate. The outputs will serve as a future rapid preclinical and clinical template for Decoy's growing portfolio of D-MAV drug candidates. Decoy believes its platform architecture may allow for similar clinical trial designs across multiple D-MAV candidates, subject to
More news about: Decoy Therapeutics, Inc